Recent News for FPRX - Five Prime Therapeutics, Inc.

Date Title
Jun 30 The Daily Biotech Pulse: Verrica Flags Potential Regulatory Delay, Back-To-Back FDA Approvals For Merck's Keytruda, OncoCyte Stalls Lung Nodule Malignancy Test
Jun 26 Is Five Prime Therapeutics Inc (FPRX) Going to Burn These Hedge Funds?
Jun 25 The Daily Biotech Pulse: Merck's Wonder Cancer Drug Snags Another Approval, Decision Day For Zogenix, UniQure Out-Licenses Gene Therapy
Jun 23 The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
Jun 22 Why Five Prime's Stock Is Trading Higher Today
May 15 Is Five Prime Therapeutics (FPRX) Stock a Solid Choice Right Now?
May 10 Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Just Reported And Analysts Have Been Cutting Their Estimates
May 10 Five Prime Therapeutics, Inc. (FPRX) CEO Thomas Civik on Q1 2020 Results - Earnings Call Transcript
May 8 Edited Transcript of FPRX earnings conference call or presentation 7-May-20 8:30pm GMT
May 7 Five Prime Therapeutics EPS beats by $0.11, beats on revenue
May 7 Five Prime Therapeutics Reports First Quarter 2020 Results
May 3 The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
Apr 30 Five Prime Therapeutics Announces Timing of Its First Quarter 2020 Results Conference Call
Apr 22 Five Prime Therapeutics Changes 2020 Annual Meeting to Virtual Format
Apr 14 Five Prime Therapeutics names new CEO
Apr 14 Five Prime Therapeutics Appoints Tom Civik as Chief Executive Officer
Apr 9 Here's Why Five Prime Therapeutics (NASDAQ:FPRX) Must Use Its Cash Wisely
Mar 19 The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
Mar 18 Edited Transcript of FPRX earnings conference call or presentation 27-Feb-20 9:30pm GMT
Mar 13 Five Prime Therapeutics Announces Publication of the Phase 1 Bemarituzumab Study in the Journal of Clinical Oncology
Mar 12 The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
Mar 6 Five Prime Therapeutics (FPRX) Investor Presentation - Slideshow
Mar 2 140 Biggest Movers From Friday
Feb 28 Five Prime Therapeutics, Inc. (FPRX) CEO William Ringo on Q4 2019 Results - Earnings Call Transcript
Feb 27 Five Prime Therapeutics (FPRX) Reports Q4 Loss, Misses Revenue Estimates

Back to the Main FPRX Page...